Scandion Oncology Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Net Income	-36.66	-39.2	-76.7	-51.71	-17.14	Upgrade
Depreciation & Amortization	0.45	0.97	0.88	0.6	0.28	Upgrade
Stock-Based Compensation	-	-	-	0.38	0.87	Upgrade
Other Operating Activities	7.56	-0	-	-1.14	-3.26	Upgrade
Change in Accounts Receivable	0.44	2.11	-0.66	-1.49	-0.78	Upgrade
Change in Accounts Payable	0.7	-14.54	7.03	3.55	2.8	Upgrade
Operating Cash Flow	-27.52	-50.67	-69.44	-49.8	-17.23	Upgrade
Capital Expenditures	-	-	-0.41	-0.32	-0.05	Upgrade
Sale of Property, Plant & Equipment	-	0.25	-	-	-	Upgrade
Investment in Securities	0.18	0.04	0.03	-0.17	-	Upgrade
Investing Cash Flow	0.18	0.29	-0.39	-0.49	-0.05	Upgrade
Long-Term Debt Repaid	-0.29	-0.71	-0.76	-0.51	-0.23	Upgrade
Net Debt Issued (Repaid)	-0.29	-0.71	-0.76	-0.51	-0.23	Upgrade
Issuance of Common Stock	20.21	-	53.55	150.69	7.89	Upgrade
Other Financing Activities	-6.4	-	-11.06	-	-	Upgrade
Financing Cash Flow	13.51	-0.71	41.73	150.18	7.67	Upgrade
Miscellaneous Cash Flow Adjustments	-0	-	-	-	-	Upgrade
Net Cash Flow	-13.84	-51.09	-28.11	99.9	-9.61	Upgrade
Free Cash Flow	-27.52	-50.67	-69.86	-50.12	-17.27	Upgrade
Free Cash Flow Per Share	-0.12	-1.25	-1.72	-1.56	-0.88	Upgrade
Cash Interest Paid	0.55	0.99	2.97	1.98	0.12	Upgrade
Cash Income Tax Paid	-5.5	-5.5	-5.5	-4.38	-3.38	Upgrade
Levered Free Cash Flow	-16.58	-40.11	-44.78	117.15	-161.93	Upgrade
Unlevered Free Cash Flow	-16.58	-40.09	-44.47	117.62	-161.91	Upgrade
Change in Net Working Capital	-8.7	12.43	-6.45	-152.06	147.53	Upgrade

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.